SCHEMBL15928205

SCHEMBL15928205

Fc1ccc(C2=CCC=N2)c(F)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMO O15229 2/20 0.34
MAOA P21397 3/20 0.34
MAOB P27338 3/20 0.34
ALDH1A1 P00352 3/20 0.34
MEN1 O00255 2/20 0.34
HPGD P15428 2/20 0.34
KMT2A Q03164 2/20 0.34
THRB P10828 1/20 0.34
PDE3B Q13370 1/20 0.33
PDE3A Q14432 1/20 0.33
TDP2 O95551 1/20 0.33
KIT P10721 1/20 0.32
ALPL P05186 2/20 0.32
KDM4E B2RXH2 1/20 0.32
USP2 O75604 1/20 0.32
DHFR P00374 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
LMNA P02545 1/20 0.32
TTR P02766 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28945029 0.77 NISCH (0.38) ALDH1A1MEN1HPGDKMT2AKDM4E
SCHEMBL19072697 0.73 MAOA (0.32) KMOMAOAMAOBALDH1A1MEN1
SCHEMBL9135463 0.70 ALDH1A1 (0.52) KMOALDH1A1MEN1HPGDKMT2A
SCHEMBL29405462 0.66 ALDH1A1 (0.41) MAOAMAOBALDH1A1KITALPL
SCHEMBL434353 0.65 ALDH1A1 (0.42) KMOMAOAMAOBALDH1A1MEN1
SCHEMBL19072690 0.64 MAOA (0.38) KMOMAOAMAOBALDH1A1PDE3B
SCHEMBL29534134 0.64 AKR1C3 (0.50) PDE3BPDE3AMAPK14
SCHEMBL20654512 0.64 AKR1C3 (0.50) PDE3BPDE3AMAPK14
SCHEMBL10880616 0.64 KMO (0.35) KMOALDH1A1MEN1HPGDKMT2A
SCHEMBL13674310 0.63 NFE2L2 (0.50) ALDH1A1MEN1HPGDKMT2ATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9656953-B2 Inhibition of cell proliferation UNIVERSITY OF SOUTH FLORIDA (US) 2017-05-23 US disclosed
US-20140221658-A1 INHIBITION OF CELL PROLIFERATION UNIVERSITY OF SOUTH FLORIDA (US) 2014-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140221658-A1 INHIBITION OF CELL PROLIFERATION RB1, RAF1, NRAS KMO 4475/4885MAOA 3543/4885MAOB 3711/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.